Search Close Search
Search Close Search


Research Strategies


Identifying Biomarkers for Therapeutics of Facioscapulohumeral Muscular Dystrophy

Dr. Emerson and colleagues are pursuing complementary research projects that aim to identify genetic modifiers and disease biomarkers of Facioscapulohumeral Muscular Dystrophy (FSHD). They also aim to develop novel animal models of FSHD, which will facilitate studies of the pathogenesis of FSHD, and provide models for preclinical studies to develop FSHD therapeutics.


facioscapulohumeral muscular dystrophy

Page Menu

Facioscapulohumeral Muscular Dystrophy Investigator

Charles Emerson Jr. PhD

Professor of neurology and Director of the Wellstone Muscular Dystrophy Program

Emerson Lab

Clinical Trials

At the Li Weibo Institute for Rare Diseases Research, our researchers and clinicians are dedicated to finding new treatment options for patients. Our clinical trials program is another way we continue to advance treatments and make new discoveries. If you or someone you know may be interested in a clinical trial, please subscribe for updates and you will be notified when we open up a new trial.


Research That Gives Hope